Getting enough bottles to keep up with 300 per cent monthly growth was one of the biggest problems for SleepDrops naturopath, medical herbalist and nutritionist Kirsten Taylor.
She told the PwC Herald Talks breakfast this morning of overcoming many issues to expand the business, now targeting the US$800 million ($1.2 billion) sleep medication market in global expansion plans.
READ MORE:
• SleepDrops targets $1.2b market
• Small Business: Absenteeism and presenteeism - Kirsten Taylor, SleepDrops
The bottles were coming from Germany via only two annual production runs, so the decision was taken to ship them here from China by boat.
She also told how "one major international airline" was allowing pilots to use SleepDrops and how 53 per cent of pilots were falling asleep involuntarily and when they woke, up to 40 per cent of their co-pilots were asleep beside them.